ulcerative colitis
| 4 min read
By using phages to deliver genes for therapeutic proteins, biologic drug delivery could become much easier.
| 5 min read
Jeremy Gale leads Pfizer’s inflammation & immunology research program to develop new therapies for moderate to severe inflammatory bowel disease.
Available on Demand
Spatial biology platforms shed light on the cellular and molecular players underlying ulcerative colitis and Crohn’s disease.
Page 1 of 1 - 3 Total Items
